ESC Action Center

Welcome to the ESC Action Center, where you’ll find breaking news and insights from the 2025 European Society of Cardiology (ESC) Congress. Explore pivotal presentations, innovative research findings, and emerging treatments to stay at the forefront of the latest advancements in cardiology.

LikeLikedUnlike

Optimizing Outcomes in Patients With oHCM: The Emerging Role of Cardiac Myosin Inhibitors
CME/CE Broadcast Replay
Optimizing Outcomes in Patients With oHCM: The Emerging Role of Cardiac Myosin Inhibitors
- Iacopo Olivotto, MD
  Peer
- Ahmad Masri, MD, MS
  Peer
- Pablo Garcia-Pavia, MD, PhD
  Peer
- Fabian Knebel, MD, PhD
  Peer
- Caroline Coats, MD
  Peer
0.50 credits
Crossing Boundaries: CETP Inhibitors and the Next Frontier in Lipid Control
CME/CE Broadcast Replay
Crossing Boundaries: CETP Inhibitors and the Next Frontier in Lipid Control
- Prof. Ulrich Laufs
  Peer
- Pam R. Taub, MD, FACC, FASPC
  Peer
- Prof. John Kastelein, Chief Scientific Officer, NewAmsterdam Pharma
  Peer
- Christie Ballantyne, MD
  Peer
0.50 credits
New Insights in the Management of HCM: Exploring the Clinical Spectrum
CME/CE Broadcast Replay
New Insights in the Management of HCM: Exploring the Clinical Spectrum
- Milind Y. Desai, MD, MBA
  Peer
- Iacopo Olivotto, MD
  Peer
- Elena Arbelo, MD, PhD
  Peer
0.50 credits
advertisement

Efficacy of Obicetrapib Across Diverse Background Lipid-Lowering Regimens: Pooled BROADWAY & BROOKLYN Analyses
Cardiology
Efficacy of Obicetrapib Across Diverse Background Lipid-Lowering Regimens: Pooled BROADWAY & BROOKLYN Analyses
- Kausik Ray, MBChB, MD, MPhil
  Peer
CETP Inhibition and Obicetrapib: A New Era in Lipid Management
Cardiology
CETP Inhibition and Obicetrapib: A New Era in Lipid Management
- Kausik Ray, MBChB, MD, MPhil
  Peer
CETP Inhibition With Obicetrapib: Implications for Cardiovascular Event Prevention
Cardiology
CETP Inhibition With Obicetrapib: Implications for Cardiovascular Event Prevention
- Stephen Nicholls, FRACP, FACC, FESC, FAHA
  Peer
advertisement